A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate Bladder and Kidney.
-
- STATUS
- Recruiting
-
- End date
- Aug 21, 2025
-
- participants needed
- 1000
-
- sponsor
- Meir Medical Center
Summary
Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.
Details
| Condition | Malignant neoplasm of prostate, Prostate Cancer, Prostate Cancer, Early, Recurrent, urinary tract neoplasm, Urologic Cancer, Malignant neoplasm of kidney, Kidney Cancer, Renal Cancer, Nephropathy, Nephropathy, Kidney Disease, Kidney Disease (Pediatric), Prostatic disorder, Prostate Disorders, bladder cancer, bladder cancer, Bladder Carcinoma, Urothelial Cancer, bladder disorder, Bladder Disorders, Prostate Disorders, Kidney Disease (Pediatric), Prostate Cancer, Early, Recurrent, Urothelial Cancer, Kidney Cancer, Prostate Cancer, Kidney Disease, Bladder Disorders, Renal Cancer, Bladder Carcinoma, Urologic Cancer, prostate carcinoma, carcinoma of the bladder, cancer, renal, prostate cancers, bladder tumor |
|---|---|
| Clinical Study Identifier | NCT02186925 |
| Sponsor | Meir Medical Center |
| Last Modified on | 21 January 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer